MicroRNA-766 contributes to high glucose-induced cardiomyocyte apoptosis by targeting exchange protein directly activated by cyclic adenylic acid isoform 1
Zhenhua Sun, Weiwei Liang, Hongyu Guan, Hai Li, Xiaoying He, Juan Liu, Liehua Liu
Abstract
Zhenhua Sun, Weiwei Liang, Hongyu Guan, Hai Li, Xiaoying He, Juan Liu, Liehua Liu
Abstract
Objective To investigate the expression levels and functional role of microRNA 766 (miR-766) in cardiomyocytes treated with high glucose conditions. Method Cardiomyocytes were cultured with different concentrations of glucose levels at 5.0 mmol/L (Controls), 15, 25 or 35 mmol/L, respectively. The expression of miR-766 was detected by real-time PCR, apoptosis was detected by flow cytometry, and the expressions of exchange protein directly activated by cyclic adenylic acid isoform 1 (Epac-1), Bax and cleaved cysteinyl aspartate specific proteinase-3 (caspase-3) were determined by Western blot. The target gene of miR-766 calculated by bioinformatics was further determined by using dual luciferase system. T test was used for comparison between groups. Results Compared with the controls, the expressions of miR-766 were significantly upregulated in different high glucose (HG)-stimulated cardiomyocytes (3.40±0.38, 4.61±0.34, 6.17±0.42 vs 0.97±0.04, t=11.131-21.493, all P<0.05). Inhibition of miR-766 in cardiomyocytes treated with HG resulted in reduced apoptosis [(16.43±0.31)% vs (26.45±0.31)%, t=-39.566, P<0.05]. Overexpression of miR-766 decreased the protein levels of Epac-1 (0.48±0.07 vs 1.00±0.12, t=-6.695, P<0.05), and inhibition of miR-766 increased the protein levels of Epac-1 (1.23±0.12 vs 0.70±0.10, t=5.884, P<0.05). Luciferase reporter assays showed that overexpression of miR-766 significantly decreased the luciferase activity of wild-type reporter, and inhibition of miR-766 significantly increased the luciferase activity of wild-type reporter (3.22±0.07 vs 5.01±0.96; 6.98±0.61 vs 5.01±0.96, t=-3.239--3.008, P<0.05). Moreover, transfection of miR-766 inhibitor could partly reverse the suppression of Epac-1 by HG in H9c2 cells (0.80±0.05 vs 0.53±0.05, t=6.810, P<0.05). Restoration of Epac-1 in miR-766-treated H9c2 cells reversed the effects of miR-766 on cleaved caspase-3 expression (0.67±0.07 vs 1.07±0.12, t=-5.050, P<0.05). Conclusion miR-766 plays an essential role in high glucose-induced cardiomyocyte apoptosis through regulating Epac-1 expression. Key words: Diabetic cardiomyopathies; Apoptosis; MicroRNAs, miR-766; Exchange protein directly activated by cyclic adenylic acid isoform 1
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression levels and functional role of microRNA 766 (miR-766) in cardiomyocytes treated with high glucose conditions. Method Cardiomyocytes were cultured with different concentrations of glucose levels at 5.0 mmol/L (Controls), 15, 25 or 35 mmol/L, respectively. The expression of miR-766 was detected by real-time PCR, apoptosis was detected by flow cytometry, and the expressions of exchange protein directly activated by cyclic adenylic acid isoform 1 (Epac-1), Bax and cleaved cysteinyl aspartate specific proteinase-3 (caspase-3) were determined by Western blot. The target gene of miR-766 calculated by bioinformatics was further determined by using dual luciferase system. T test was used for comparison between groups. Results Compared with the controls, the expressions of miR-766 were significantly upregulated in different high glucose (HG)-stimulated cardiomyocytes (3.40±0.38, 4.61±0.34, 6.17±0.42 vs 0.97±0.04, t=11.131-21.493, all P<0.05). Inhibition of miR-766 in cardiomyocytes treated with HG resulted in reduced apoptosis [(16.43±0.31)% vs (26.45±0.31)%, t=-39.566, P<0.05]. Overexpression of miR-766 decreased the protein levels of Epac-1 (0.48±0.07 vs 1.00±0.12, t=-6.695, P<0.05), and inhibition of miR-766 increased the protein levels of Epac-1 (1.23±0.12 vs 0.70±0.10, t=5.884, P<0.05). Luciferase reporter assays showed that overexpression of miR-766 significantly decreased the luciferase activity of wild-type reporter, and inhibition of miR-766 significantly increased the luciferase activity of wild-type reporter (3.22±0.07 vs 5.01±0.96; 6.98±0.61 vs 5.01±0.96, t=-3.239--3.008, P<0.05). Moreover, transfection of miR-766 inhibitor could partly reverse the suppression of Epac-1 by HG in H9c2 cells (0.80±0.05 vs 0.53±0.05, t=6.810, P<0.05). Restoration of Epac-1 in miR-766-treated H9c2 cells reversed the effects of miR-766 on cleaved caspase-3 expression (0.67±0.07 vs 1.07±0.12, t=-5.050, P<0.05). Conclusion miR-766 plays an essential role in high glucose-induced cardiomyocyte apoptosis through regulating Epac-1 expression. Key words: Diabetic cardiomyopathies; Apoptosis; MicroRNAs, miR-766; Exchange protein directly activated by cyclic adenylic acid isoform 1
Key concepts: Apoptosis, Western blot, Gene isoform, Flow cytometry, Molecular biology, Chemistry, microRNA, Downregulation and upregulation